Activation of the central histaminergic system is involved in hypoxia-induced stroke tolerance in adult mice

Journal of Cerebral Blood Flow and Metabolism

Volumn 31, Issue 1, 2011, Pages 305-314

  Fan, Yan Ying ^a   Hu, Wei Wei ^a   Dai, Hai Bin ^a   Zhang, Jian Xiang ^a   Zhang, Lu Yi ^a   He, Ping ^a   Shen, Yao ^a   Ohtsu, Hiroshi ^b   Wei, Er Qing ^a   Chen, Zhong ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

histamine; hypoxic preconditioning; vascular endothelial growth factor

Indexed keywords

ALPHA FLUOROMETHYLHISTIDINE; HISTAMINE; HISTIDINE DECARBOXYLASE; MESSENGER RNA; SU 1498; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN INFARCTION; BRAIN INFARCTION SIZE; CONTROLLED STUDY; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOXIA; KNOCKOUT MOUSE; LASER DOPPLER FLOWMETRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION; STROKE; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; BRAIN CHEMISTRY; CEREBROVASCULAR CIRCULATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CINNAMATES; HISTAMINE; HISTIDINE DECARBOXYLASE; HYPOXIA, BRAIN; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC ATTACK, TRANSIENT; ISCHEMIC PRECONDITIONING; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STROKE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 78650876625     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/jcbfm.2010.94     Document Type: Article

References (38)

1. Adachi N (2005) Cerebral ischemia and brain histamine. Brain Res Brain Res Rev 50:275-86
2. Bernaudin M, Nedelec AS, Divoux D, MacKenzie ET, Petit E, Schumann-Bard P (2002) Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxiainducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J Cereb Blood Flow Metab 22:393-403
3. Chen Z (2001) Effect of clobenpropit on regional cerebral blood flow in rat hippocampus. Acta Pharmacol Sin 22:355-60
4. Cianchi F, Cortesini C, Schiavone N, Perna F, Magnelli L, Fanti E, Bani D, Messerini L, Fabbroni V, Perigli G, Capaccioli S, Masini E (2005) The role of cyclooxygenase-2 in mediating the effects of histamine on cell proliferation and vascular endothelial growth factor production in colorectal cancer. Clin Cancer Res 11:6807-15
5. Dai H, Zhang Z, Zhu Y, Shen Y, Hu W, Huang Y, Luo J, Timmerman H, Leurs R, Chen Z (2006) Histamine protects against NMDA-induced necrosis in cultured cortical neurons through H receptor/cyclic AMP/protein kinase A and H receptor/GABA release pathways. J Neurochem 96:1390-400
6. Diaz-Trelles R, Novelli A, Vega JA, Marini A, Fernandez-Sanchez MT (2000) Antihistamine terfenadine potentiates NMDA receptor-mediated calcium influx, oxygen radical formation, and neuronal death. Brain Res 880:17-27
7. Dirnagl U, Simon RP, Hallenbeck JM (2003) Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 26:248-54
8. Garbarg M, Barbin G, Rodergas E, Schwartz JC (1980) Inhibition of histamine synthesis in brain by alphafluoromethylhistidine, a new irreversible inhibitor: in vitro and in vivo studies. J Neurochem 35:1045-52
9. Ghosh AK, Hirasawa N, Ohuchi K (2001) Enhancement by histamine of vascular endothelial growth factor production in granulation tissue via H(2) receptors. Br J Pharmacol 134:1419-28
10. Ghosh AK, Hirasawa N, Ohtsu H, Watanabe T, Ohuchi K (2002) Defective angiogenesis in the inflammatory granulation tissue in histidine decarboxylase-deficient mice but not in mast cell-deficient mice. J Exp Med 195:973-82
11. Haas H, Panula P (2003) The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci 4:121-30
12. Hayashi T, Abe K, Itoyama Y (1998) Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia. J Cereb Blood Flow Metab 18:887-95
13. Inaba S, Iwai M, Tomono Y, Senba I, Furuno M, Kanno H, Okayama H, Mogi M, Higaki J, Horiuchi M (2009) Exaggeration of focal cerebral ischemia in transgenic mice carrying human renin and human angiotensinogen genes. Stroke 40:597-603
14. Irisawa Y, Adachi N, Liu K, Arai T, Nagaro T (2008) Alleviation of ischemia-induced brain edema by activation of the central histaminergic system in rats. J Pharmacol Sci 108:112-23
15. Iwanami J, Mogi M, Okamoto S, Gao XY, Li JM, Min LJ, Ide A, Tsukuda K, Iwai M, Horiuchi M (2007) Pretreatment with eplerenone reduces stroke volume in mouse middle cerebral artery occlusion model. Eur J Pharmacol 566:153-9
16. Jeong HJ, Moon PD, Kim SJ, Seo JU, Kang TH, Kim JJ, Kang IC, Um JY, Kim HM, Hong SH (2009) Activation of hypoxia-inducible factor-1 regulates human histidine decarboxylase expression. Cell Mol Life Sci 66:1309-19
17. Jin CL, Yang LX, Wu XH, Li Q, Ding MP, Fan YY, Zhang WP, Luo JH, Chen Z (2005) Effects of carnosine on amygdaloid-kindled seizures in Sprague-Dawley rats. Neuroscience 135:939-47
18. Jin KL, Mao XO, Greenberg DA (2000) Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci USA 97:10242-7
19. Laudenbach V, Fontaine RH, Medja F, Carmeliet P, Hicklin DJ, Gallego J, Leroux P, Marret S, Gressens P (2007) Neonatal hypoxic preconditioning involves vascular endothelial growth factor. Neurobiol Dis 26:243-52
20. Liu L, Zhang S, Zhu Y, Fu Q, Gong Y, Ohtsu H, Luo J, Wei E, Chen Z (2007) Improved learning and memory of contextual fear conditioning and hippocampal CA1 long-term potentiation in histidine decarboxylase knock-out mice. Hippocampus 17:634-41
21. Longa EZ, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91
22. Madl JE, Royer SM (1999) Glutamate in synaptic terminals is reduced by lack of glucose but not hypoxia in rat hippocampal slices. Neuroscience 94:417-30
23. Manoonkitiwongsa PS, Schultz RL, McCreery DB, Whitter EF, Lyden PD (2004) Neuroprotection of ischemic brain by vascular endothelial growth factor is critically dependent on proper dosage and may be compromised by angiogenesis. J Cereb Blood Flow Metab 24:693-702
24. Matsuzaki H, Tamatani M, Yamaguchi A, Namikawa K, Kiyama H, Vitek MP, Mitsuda N, Tohyama M (2001) Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades. FASEB J 15:1218-20
25. Miller BA, Perez RS, Shah AR, Gonzales ER, Park TS, Gidday JM (2001) Cerebral protection by hypoxic preconditioning in a murine model of focal ischemiareperfusion. Neuroreport 12:1663-9
26. Ohyu J, Endo A, Itoh M, Takashima S (2000) Hypocapnia under hypotension induces apoptotic neuronal cell death in the hippocampus of newborn rabbits. Pediatr Res 48:24-9
27. Prass K, Scharff A, Ruscher K, Lowl D, Muselmann C, Victorov I, Kapinya K, Dirnagl U, Meisel A (2003) Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin. Stroke 34:1981-6
28. Qiu MH, Zhang R, Sun FY (2003) Enhancement of ischemia-induced tyrosine phosphorylation of Kv1.2 by vascular endothelial growth factor via activation of phosphatidylinositol 3-kinase. J Neurochem 87:1509-17
29. Shen Y, Hu WW, Fan YY, Dai HB, Fu QL, Wei EQ, Luo JH, Chen Z (2007) Carnosine protects against NMDAinduced neurotoxicity in differentiated rat PC12 cells through carnosine-histidine-histamine pathway and H(1)/H(3) receptors. Biochem Pharmacol 73:709-17
30. Suzuki G, Chen Z, Sugimoto Y, Fujii Y, Kamei C (1999) Effects of histamine and related compounds on regional cerebral blood flow in rats. Methods Find Exp Clin Pharmacol 21:613-7
31. Vogel J, Horner C, Haller C, Kuschinsky W (2003) Heterologous expression of human VEGF165 in rat brain: dose-dependent, heterogeneous effects on CBF in relation to vascular density and cross-sectional area. J Cereb Blood Flow Metab 23:423-31
32. Wang L, Zhang Z, Wang Y, Zhang R, Chopp M (2004) Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35:1732-7
33. Waskiewicz J, Molchanova L, Walajtys-Rode E, Rafalowska U (1988) Hypoxia and ischemia modifies histamine metabolism and transport in brain synaptosomes. Resuscitation 16:287-93
34. Wick A, Wick W, Waltenberger J, Weller M, Dichgans J, Schulz JB (2002) Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J Neurosci 22:6401-7
35. Xie Z, Moir RD, Romano DM, Tesco G, Kovacs DM, Tanzi RE (2004) Hypocapnia induces caspase-3 activation and increases Abeta production. Neurodegener Dis 1:29-37
36. Yasuhara T, Shingo T, Muraoka K, wen Ji Y, Kameda M, Takeuchi A, Yano A, Nishio S, Matsui T, Miyoshi Y, Hamada H, Date I (2005) The differences between high and low-dose administration of VEGF to dopaminergic neurons of in vitro and in vivo Parkinson's disease model. Brain Res 1038:1-10
37. Yu GL, Wei EQ, Wang ML, Zhang WP, Zhang SH, Weng JQ, Chu LS, Fang SH, Zhou Y, Chen Z, Zhang Q, Zhang LH (2005) Pranlukast, a cysteinyl leukotriene receptor-1 antagonist, protects against chronic ischemic brain injury and inhibits the glial scar formation in mice. Brain Res 1053:116-25
38. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, Bruggen N, Chopp M (2000) VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 106:829-38